![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-5592|14|12|1405-1420
ISSN: 1389-4501
Source: Current Drug Targets, Vol.14, Iss.12, 2013-11, pp. : 1405-1420
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Anti-cytokines and Cytokines in the Treatment of Rheumatoid Arthritis
Current Pharmaceutical Design, Vol. 9, Iss. 14, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Page C.
Pulmonary Pharmacology & Therapeutics, Vol. 15, Iss. 5, 2002-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Mucosal Healing and anti TNFs in IBD
Current Drug Targets, Vol. 11, Iss. 2, 2010-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cell Therapies for IBD: What Works?
Current Drug Targets, Vol. 14, Iss. 12, 2013-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
New mesalazine formulation advantageous in IBD
Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. :